November 27, 2018 / 5:58 AM / 6 months ago

Swiss stocks - Factors to watch on Nov. 27

ZURICH/BERLIN, Nov 27 (Reuters) - The Swiss blue-chip SMI was seen opening 0.1 percent lower at 8,921 points on Tuesday, according to premarket indications by bank Julius Baer .

Here are some of the main factors that may affect Swiss stocks:


The drugmaker’s Alcon eyecare unit, which is being spun off to shareholders in 2019, plans to pay a dividend in 2020 and will focus on “bolt-on” acquisitions to help boost operating margins to the mid-20 percent range, from the high-teens now.

Its Sandoz generics division won European approval for a biosimilar version of Amgen’s Neulasta.


Orior CFO Ricarda Demarmels will step down from her role to become Emmi’s CFO next year.


* Roche’s Genentech announced the U.S. FDA had approved an autoinjector for treating arthritis.

* Dottikon said sales fell 19 percent in the first half to 56.6 million francs, as operating margins slipped and net income tumbled to 2 million francs, from nearly 10 million in the year earlier.

* Barry Callebaut and Garudafood extended their supply partnership in Indonesia.


CREDIT SUISSE GROUP - Morgan Stanley cuts to “equal-weight” from “overweight”

GEBERIT - Credit Suisse cuts to “neutral” from “outperform”


No Swiss economic data scheduled

Reporting by Zurich newsroom and Berlin Speed Desk

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below